ALSO NOTED: Nuvelo gains equity financing; First federal Vioxx trial scheduled; Anadys prices stock offering; and much more...

> Nuvelo has lined up an equity financing facility for up to $75 million. Report

> The first federal case on Vioxx is scheduled to start November 28 and focus on the death of a 53-year-old Florida man. Story

> San Diego-based Anadys has priced a stock offering of 5 million shares at $12.40 each. Release

> DOV Pharmaceutical of Hackensack, New Jersey, has begun a Phase III trial of bicifadine in the treatment of post-operative pain following vaginal hysterectomy. Release

> Sankyo has granted Schering-Plough marketing rights to the hypertension drug olmesartan in several Latin American countries. Release

And Finally... The World Health Organization is pressing China to find out why a bacterial disease in pigs has led to 38 deaths. Story